SILO PHARMA, INC. Gain (Loss) on Investments
SILO PHARMA, INC. (SILO) reported Gain (Loss) on Investments of $2.56 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2023-11-13
- SILO PHARMA, INC. gain (loss) on investments for the quarter ending 2023-09-30 was $2.56K.
- SILO PHARMA, INC. gain (loss) on investments for the quarter ending 2023-06-30 was -$2.18K.
- SILO PHARMA, INC. gain (loss) on investments for the quarter ending 2023-03-31 was $390.00.
- SILO PHARMA, INC. gain (loss) on investments for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- SILO PHARMA, INC. gain (loss) on investments for fiscal 2022 was -$104.70K, a 101.57% decline from fiscal 2021.
- SILO PHARMA, INC. gain (loss) on investments for fiscal 2021 was $6.66M.
- SILO PHARMA, INC. gain (loss) on investments for fiscal 2013 was $104.90K.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2023-09-30 | $2.56K 10-Q · filed 2023-11-13 | $379.00 derived: sum of 2 quarters · filed 2023-11-13 | -$723.00 10-Q · filed 2023-11-13 | $769.00 derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$2.18K 10-Q · filed 2023-08-11 | -$2.18K 10-Q · filed 2023-08-11 | -$1.79K derived: sum of 3 quarters · filed 2023-08-11 | -$1.79K derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $390.00 10-Q · filed 2023-05-12 | $390.00 derived: sum of 2 quarters · filed 2023-05-12 | $390.00 derived: sum of 3 quarters · filed 2023-05-12 | -$104.31K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $0.00 derived: sum of 2 quarters · filed 2023-03-24 | -$104.70K derived: sum of 3 quarters · filed 2023-08-11 | -$104.70K 10-K · filed 2023-03-24 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$104.70K derived: sum of 2 quarters · filed 2023-08-11 | -$104.70K 10-Q · filed 2022-11-10 | -$261.13K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | -$104.70K 10-Q · filed 2023-08-11 | -$104.70K 10-Q · filed 2023-08-11 | -$261.13K derived: sum of 3 quarters · filed 2023-08-11 | $6.39M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$161.80K 10-Q · filed 2023-05-12 | -$156.44K derived: sum of 2 quarters · filed 2023-05-12 | $6.50M derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $5.36K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $6.66M derived: sum of 2 quarters · filed 2023-03-24 | $6.66M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $6.66M 10-Q · filed 2022-11-10 | $6.66M 10-Q · filed 2022-11-10 | ||
| 2018-09-30 | -$117.00K 10-Q · filed 2018-11-14 | -$204.43K 10-Q · filed 2018-11-14 | ||
| 2017-09-30 | -$427.49K 10-Q · filed 2018-11-14 | $450.71K 10-Q · filed 2018-11-14 | ||
| 2013-12-31 | $104.90K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |